Bill Texts: US SB4152 | 2021-2022 | 117th Congress

Bill Title: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Spectrum:

Status: (Introduced - Dead) 2022-05-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB4152 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2022-05-10PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress SB4152

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress SB4152 currently on file.

Social Comments on US SB4152

feedback